A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
For patients and caregivers, ADRD-DM presents unique challenges for detecting and preventing hypoglycemia.Individualized care for people with ADRD-DM should be based on patient and caregiver goals along with patients’ cognitive and physical abilities, reported outcomes, and hypoglycemia risk, based largely on prior hypoglycemic events. Providing details of hypoglycemic events and risks …
The purpose of this research is to determine whether common tests of memory and thinking can be administered by video on a computer or tablet, and if these tests are useful when administered this way as compared to being given in person.
What is this study about?The purpose of this study is to assess the safety, tolerability, immunogenicity and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndrome.This phase 1b/2 study will be in 2 parts. Study Part 1 will involve subjects with prodromal …
What is the purpose of this study?The purpose of the study is to learn about the gait characteristics of persons with Alzheimer’s disease and related dementias (ADRD). We also want to understand how we should design and implement a tool to monitor gait. To this end, the "Gait Monitoring Study" …
The overall goal of the DISCOVERY study is to better understand what factors contribute tohanges in cognitive (i.e., thinking and memory) abilities in patients who experienced ake. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking and other mental abilities …
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents thezed integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD2019 and beyond.
We are doing this research to test a new method of diagnosing Alzheimer’s Disease using a blood test and an injection of a diabetes drug called pramlintide. You will receive one dose of this medication at each of two visits. This study is conducted at three medical centers in Indianapolis …
Who is Eligible Ages 18+ Must have had symptoms of Alzheimer’s disease prior to age 65 Diagnosis of Alzheimer’s disease Must be able to complete MRI Must be able to tolerate lumbar puncture No history of seizures, stroke or cancer in the last 5 years What is Involved In-person visits …
A Phase II/III randomized, double-blind, placebo-controlled, cognitiveendpoint, multicenter study of potential disease modifying therapies inindividuals at risk for and with dominantly inherited Alzheimer’s disease.
